Contrastingly, pDCs under the influence of primary breast tumor cell-derived granulocyte-macrophage colony-stimulating factor (GM-CSF) were shown to present a tolerogenic phenotype and aid in tumor progression [78]. This evidence concerns the gene CSF2 and breast neoplasm.